Allied Market Research published a report, titled, ‘Post-Traumatic Stress Disorder Treatment Market by Treatment Type (Drugs, Pyschotherapy), By Age Group (Pediartic, Geriatric, Adult), By End User (Hospitals, Outpaitent Clinics, Mental Health Center, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031.‘ According to the report, the global post-traumatic stress disorder treatment industry was estimated at $16.0 billion in 2021, and is anticipated to hit $26.1 billion by 2031, registering a CAGR of 4.9% from 2022 to 2031.
Post-traumatic stress disorder (PTSD) is a mental health condition triggered by either experiencing it or witnessing it. Post-traumatic stress disorder treatment help to improve in patient’s thinking power, changes in physical activity & regains a sense of control over life. The mode of treatment applied for post-traumatic stress disorder includes medication, therapies, self-care & nutrition.
Download Report (245 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/12965
Key players in the industry-
- Behavioral Health Network, Inc.
- CareTech Holdings Plc
- GlaxoSmithKline Plc
- Viatris, Inc
- North Range Behavioral Health
- Strategic Behavioral Health
- Pyramid Healthcare
- Pfizer, Inc
- Eily Lilly and Company
- Acadia Healthcare
- Ascension Seton
Key Market Segments
- By Treatment Type
- Drugs
- Pyschotherapy
- By Age Group
- Pediartic
- Geriatric
- Adult
- By End User
- Mental Health Center
- Others
- Hospitals
- Outpaitent Clinics
Specific Requirement on COVID-19? Ask to Our Industry Expert:
https://www.alliedmarketresearch.com/request-for-customization/12965?reqfor=covid